CONMED Corporation
CNMD
NYSE·Healthcare·Medical - Devices·Mkt cap $1.5B
$49.32
▼ -0.20%
P/E
26.63
Mkt Cap
$1.5B
52-Wk Range
$31.44–$56.64
52-Week Range
$31.44 - $56.64
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 8.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary minimally invasive surgical technology platforms with strong clinical outcomes and surgeon adoption
- Established brand portfolio (Hall, CONMED Linvatec, Concept, Shutt) with deep relationships across hospitals and surgery centers
- Diversified product mix across multiple surgical specialties reduces dependence on single market segment
- Direct sales force and distributor network providing strong market access and customer relationships
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Steady revenue growth (5% YoY)
Value
Undervalued - trading well below Medical Devices peers
Momentum
Hot
+40.3% over 3m
Quality
Strong
Excellent business quality
Dividend
Token
0.41% yield
Smart-money signal
Who's buying CNMD right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 28, 2026
JUL 29, 2026
Reported EPS of $1.38 vs $1.11 consensus (+24.3% surprise). Revenue of $343.5M vs $337.6M expected (+1.8%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+24.3%
Revenue trend · last 8Q
—
+6%
+3%
+3%
+7%
+8%
-1%
+0%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$316.7M
$345.9M
$321.3M
$342.3M
$337.9M
$373.2M
$317.0M
$343.5M
Margins · last 8Q
Gross
57.5%
Operating
10.6%
Profit
6.7%
Wall Street consensus
6 analysts · 0% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
0%
Hold
83%
Sell
17%
Median Price Target
—
Latest: Needham · Jul 13, 2026
vs Industry
How CNMD stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related